Dosage and administration
Sensitivity test is strongly advised prior to use. Apply to area for temporary relief. Do not use more than 2 times a day.
Sensitivity test is strongly advised prior to use. Apply to area for temporary relief. Do not use more than 2 times a day.
5.00% LIDOCAINE HYDROCHLORIDE, 2.00% TETRACAINE HYDROCHLORIDE, 0.02% RACEPINEPHRINE HYDROCHLORIDE
DEIONIZED WATER, SODIUM METABISULFITE, SODIUM CHLORIDE, PROPYLENE GLYCOL, METHYLPARABEN, PROPYLPARABEN, DIAZOLIDINYL UREA, AND TETRASODIUM EDTA.
For temporary relief of pain and swelling.
Sensitivity test is strongly advised prior to use. Apply to area for temporary relief. Do not use more than 2 times a day.
CLIENT EYE PROTECTANT SUGGESTED
Do not get in the mouth or eyes. Do not use product if you are pregnant or a nursing mother.
Keep out of the reach of children. If product comes into contact with the eyes wash immediately. If accidentally swallowed seek immediate medical attention.
Do not use this product if you have any allergies to any of the product ingredients.
DISCONTINUE USE IF YOU HAVE SKIN IRRITATION OR SENSITIVITY.
Distributed by Trilab Products Inc. 714.839.6543.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84112-008 | 84112-008-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Lidocaine Hydrochloride | V13007Z41A | ACTIR |
| Tetracaine Hydrochloride | 5NF5D4OPCI | ACTIB |
| Racepinephrine Hydrochloride | 336096P2WE | ACTIM |
| SODIUM METABISULFITE | 4VON5FNS3C | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
| Water | 059QF0KO0R | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Propylparaben | Z8IX2SC1OH | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Diazolidinyl Urea | H5RIZ3MPW4 | IACT |
| EDETATE SODIUM | MP1J8420LU | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 167b9e84-727a-4cde-a32c-d2b5003d036d | a50b14f8-114d-49cd-a596-08d167cbe89b | 2024-07-11 | Warnings | a50b14f8-114d-49cd-a596-08d167cbe89b |
Adverse event summaries are temporarily unavailable. Other product information remains available.